Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting.
Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting. Pharmacoepidemiol Drug Saf. 2022 04; 31(4):411-423.